Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Ogier

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Investigational New Drugs|May 27, 2020
Translational approach from preclinical to clinical: comparison of dose finding methods of a new Bcl2 inhibitor using PK-PD modeling and interspecies extrapolationPhilippe B Pierrillas, Emilie Henin, Julien Ogier, et al.
Pharmaceutical Research|November 30, 2012
In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA deliveryAoife M O'Mahony, Stephane Desgranges, Julien Ogier, et al.
Organic & Biomolecular Chemistry|July 10, 2010
Enhanced drug loading in polymerized micellar cargoJulien Ogier, Thomas Arnauld, Géraldine Carrot, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 2019
Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation StrategyPhilippe B Pierrillas, Emilie Henin, Kathryn Ball, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 13, 2011
Tumor-targeted polydiacetylene micelles for in vivo imaging and drug deliveryNicolas Mackiewicz, Edmond Gravel, Anikitos Garofalakis, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Investigational New Drugs|May 27, 2020
Translational approach from preclinical to clinical: comparison of dose finding methods of a new Bcl2 inhibitor using PK-PD modeling and interspecies extrapolationPhilippe B Pierrillas, Emilie Henin, Julien Ogier, et al.
Pharmaceutical Research|November 30, 2012
In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA deliveryAoife M O'Mahony, Stephane Desgranges, Julien Ogier, et al.
Organic & Biomolecular Chemistry|July 10, 2010
Enhanced drug loading in polymerized micellar cargoJulien Ogier, Thomas Arnauld, Géraldine Carrot, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 2019
Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation StrategyPhilippe B Pierrillas, Emilie Henin, Kathryn Ball, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 13, 2011
Tumor-targeted polydiacetylene micelles for in vivo imaging and drug deliveryNicolas Mackiewicz, Edmond Gravel, Anikitos Garofalakis, et al.
Pageof 2